In colon cancer, IHC analysis showed that approximately 31% of colon cancers harbor increased CARMA3 expression (123); CARMA3 knockdown in colon cancer cells resulted in decreased NF-κB activity and led to decreased proliferation and cell cycle arrest. Here, NFKB1 is linked to colonic neoplasm.